<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Studying the effects of different combinations of peak and valley doses, as well as, microbeam spacing. Experiment number: LS2748</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
				</availability>
				<date type="published" when="2018-06-30">30 June 2018</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Elke</forename><surname>Brauer-Krisch</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Anatomy</orgName>
								<orgName type="institution">University of Bern</orgName>
								<address>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Valentin</forename><surname>Djonov</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Anatomy</orgName>
								<orgName type="institution">University of Bern</orgName>
								<address>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Fernandez</forename><surname>Palomo</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Anatomy</orgName>
								<orgName type="institution">University of Bern</orgName>
								<address>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Cristian</forename><forename type="middle">#</forename><surname>Potez</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Anatomy</orgName>
								<orgName type="institution">University of Bern</orgName>
								<address>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marine</forename><forename type="middle">#</forename><surname>Trappetti</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Anatomy</orgName>
								<orgName type="institution">University of Bern</orgName>
								<address>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Studying the effects of different combinations of peak and valley doses, as well as, microbeam spacing. Experiment number: LS2748</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2018-06-30">30 June 2018</date>
						</imprint>
					</monogr>
					<idno type="MD5">805A97CFECD9E7C7CDB2993B21475DC7</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-23T14:18+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Background: In collaborative work with the Australian Synchrotron, we combined AuNPs with MRT at this facility in order to reproduce the results obtained at its European counterpart. The data from the longitudinal tumor growth showed that the MRT collimator used in the Australian Synchrotron did not reproduce the same results. The reason? Although the peak dose was the same (400 Gy MRT) the spacing between the microbeams was different; in the European Synchrotron, the spacing is 200 microns while at the Australian Synchrotron is 400 microns. We hypothesize that some factor (or parameter) related to the increase in the spacing is abolishing the characteristic tumor control after MRT, which is normally represented as a tumor shrinkage 5 days after the treatment (Figure <ref type="figure">1</ref>).</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>0 10 20 30 40 50 0 50 100 150 Days after implantation Tumor Volume (mm 3 ) Tumor Growth MRT geometry: 50um / 400 spacing Control MRT (400 Gy) BB (6.6 Gy)</p><p>Experiment at the ESRF: The discovery that the geometry of the beam is a crucial factor that influences the outcome of MRT-treated tumors, prompted the creation of a follow-up study at the European Synchrotron. This study aimed at identifying how the interaction between high-peak doses and low-valley doses, which are the results of the MRT geometry, determine the tumor control. Table <ref type="table" target="#tab_0">1</ref> shows the experimental plan and the logic behind the design of each group.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 1. Experimental design and rationale of the experiment.</head><p>The preliminary results show that a collimator with a 400-micrometer spacing can be used as long as the peak-dose is increased by 80%, which in turn directly increases the valley dose in 80%. This suggests the presence of a valleydose threshold above which MRT is effective (Figure <ref type="figure" target="#fig_1">2</ref>).  50 100 150 Days after irradiation Tumor Volume (mm 3 ) Tumor Growth -Effects of the MRT Geometry MRT (50/400) 2196Gy/6Gy MRT (50/400) 400Gy/1.1Gy BB /4.9Gy MRT (50/200) 74.58Gy/1.1Gy BB /4.9Gy Unirradiated Control MRT (50/200) 400Gy/6Gy MRT (50/400) 400Gy/1.1Gy MRT (50/200) 74.58Gy/1.1Gy</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc>Figure1. Tumor growth after MRT with a spacing of 400 microns performed at the Australian Synchrotron. All the melanomas were implanted on day 0. Tumor measurements started on day 8. The irradiation took place on day 10, which is represented by the vertical line. The BB dose was 6.6Gy, while the MRT dose was composed of peaks doses of 400 Gy and valley doses of 1.1Gy. Each group had 9 mice. Error bars indicate SEM. The solid curved-line corresponds to the best fit of a Third Order Polynomial equation.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc>Figure2. Effects of the MRT Geometry at the European Synchrotron. The melanomas were implanted on day 0 and 1 given the high number of animals for this experiment. Tumor measurements started on day 8. The irradiation took place on day 11, which is represented by the vertical line. The geometries studied were two 200 um and 400 um of spacing. The peak and valley doses were also studied according to Table 1. The dose and geometry of each group are indicated in the legend of the figure. Error bars indicate SEM.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc>The dose and geometry of each group are indicated in the legend of the figure. Error bars indicate SEM.</figDesc><table><row><cell>Group</cell><cell>Description</cell><cell cols="3">Modality Configuration microbeam spacing</cell><cell cols="2">Peak dose Valley dose Doses</cell><cell>Aim of this group</cell><cell>Doses for GUI (MSC or Film)</cell></row><row><cell>Group C</cell><cell>Best Tumor Control achieved at the ESRF</cell><cell>MRT (PVDR: 67.81)</cell><cell>50 um</cell><cell>200 ctc</cell><cell cols="3">404 Gy 6.0 (5.96) Gy Best Tumor Control achieved at the ESRF</cell><cell>400 Gy (GUI MSC)</cell></row><row><cell>Group D</cell><cell>Experiment done in Melbourne</cell><cell>MRT (PVDR: 366.3)</cell><cell>50 um</cell><cell>400 ctc</cell><cell>404 Gy</cell><cell>1.1 Gy</cell><cell>Mattia's Calculations with newest Mouse Ear Model (This replaces calculations by Liam).</cell><cell>400 Gy (GUI MSC)</cell></row><row><cell>Group E</cell><cell>Decreasing the Peak Dose</cell><cell>MRT (PVDR: 67.81)</cell><cell>50 um</cell><cell>200 ctc</cell><cell>74.58 Gy</cell><cell>1.1 Gy</cell><cell>Decreasing the Peak Dose to match the Valley Dose 28.05.2018) to "Group D" (Valley dose calculated by Mattia on</cell><cell>73.76 Gy (GUI MSC)</cell></row><row><cell>Group F</cell><cell>Increasing the Peak Dose</cell><cell>MRT (PVDR: 366.3)</cell><cell>50 um</cell><cell>400 ctc</cell><cell cols="2">2196 Gy 6.0 (5.96) Gy</cell><cell>Increasing the Peak Dose to match the Valley Dose to having larger spacing "Group C" (Best Tumor Control at the ESRF) while</cell><cell>2171 Gy (GUI MSC)</cell></row><row><cell></cell><cell>Reinfocing the Valley</cell><cell>MRT (PVDR: 366.3)</cell><cell>50 um</cell><cell>400 ctc</cell><cell>404 Gy</cell><cell>1.1 Gy</cell><cell>Reinfocing the Valley Dose of "Group D" with Broad</cell><cell>400 Gy (GUI MSC)</cell></row><row><cell>Group G</cell><cell>dose with Broad Beam</cell><cell>BB</cell><cell>-</cell><cell>-</cell><cell cols="2">4.9 Gy</cell><cell>Beam to increase the valley dose up to 5.6Gy and thus, match it to "Group C"</cell><cell>4.57 Gy (GUI Film) Gap 40</cell></row><row><cell></cell><cell>Reinfocing the Valley</cell><cell>MRT (PVDR: 67.81)</cell><cell>50 um</cell><cell>200 ctc</cell><cell>74.58 Gy</cell><cell>1.1 Gy</cell><cell>Reinfocing the Valley Dose of "Group E" with Broad</cell><cell>73.76 Gy (GUI MSC)</cell></row><row><cell>Group I</cell><cell>dose with Broad Beam</cell><cell>BB</cell><cell>-</cell><cell>-</cell><cell cols="2">4.9 Gy</cell><cell>Beam to increase the valley dose up to 5.6Gy and thus, match it to "Group C"</cell><cell>4.57 Gy (GUI Film) Gap 40</cell></row><row><cell>Group J</cell><cell>Unirradiated Tumor Control</cell><cell>-</cell><cell>-</cell><cell>-</cell><cell>-</cell><cell>-</cell><cell>-</cell><cell>-</cell></row></table></figure>
		</body>
		<back>
			<div type="references">

				<listBibl/>
			</div>
		</back>
	</text>
</TEI>
